Stay Up-To-Date With the Latest News in the DDR Inhibitors Space!
In Collaboration with DDR Beacon Target Therapies
Download our exclusive DDRi insights data infographic to discover:
- The link between ATR inhibitors (ATRi) and lung cancer
- Combination trials with PARP inhibitors (PARPi)
- The move towards targeting effector proteins by drug developer
And much more!
"Excellent overview of the current DDR, ATR and PARP field that also included forward-looking perspectives"
Executive Vice President & Chief Technology Officer - Arum Therapeutics